Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-21-068013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | 2021-12-01 | CRSP | Kulkarni Samarth | CEO, Dir | F - Tax | $75.10 | -779 | 219.2K | -0.4% | -$58.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-12-01 | F | D | 779 | $75.10 | 219,153 | D | — | — |